# Lessons of Macrophage-Associated Heart Regeneration in Fish, Amphibians, and Neonatal Mice, Applied to Adult Mice: A Perspective on α-Gal Nanoparticles

**Authors:** Uri Galili, Gary L. Schaer

PMC · DOI: 10.3390/ijms27041950 · 2026-02-18

## TL;DR

This paper explores how regenerative heart repair in animals like fish and mice could be reactivated in adult mice using α-Gal nanoparticles to trigger pro-regenerative immune responses.

## Contribution

The novel approach uses α-Gal nanoparticles to induce localized complement activation and macrophage recruitment for heart regeneration in post-MI adult mice.

## Key findings

- α-Gal nanoparticles induce localized complement activation and recruit pro-regenerative macrophages to injured myocardium.
- This process leads to near-complete regeneration of the injured heart within 14 days in mice.
- The method mimics neonatal regenerative mechanisms suppressed in adult mice.

## Abstract

An ancient evolutionary regenerative mechanism of injured myocardium in vertebrates has been conserved in zebrafish, urodeles (salamander, newt, and axolotl) and neonatal mice. This innate regenerative mechanism is characterized by extensive migration of pro-regenerative macrophages into the injured myocardium and non-immune activation of parts of the complement system. Loss of regenerative activity in neonatal mice within a few days after birth implies that it is suppressed and replaced by fibrotic repair and scar formation. Fibrosis prevents ventricular wall rupture following myocardial infarction (MI), but it compromises contractility and can lead to heart failure and premature death. Reactivation of the suppressed regenerative mechanism in post-MI adult mice may be feasible by localized immune activation of the complement system, resulting in extensive recruitment of pro-regenerative macrophages into the injured myocardium, recapitulating neonatal mechanisms. Localized complement activation can be achieved by a new method of harnessing the natural anti-Gal antibody, which constitutes ~1% of human immunoglobulins and binds the carbohydrate antigen “α-gal epitope”. α-Gal nanoparticles (small liposomes presenting multiple α-gal epitopes) bind anti-Gal when administered into reperfused myocardium post-MI in anti-Gal-producing mice, thereby inducing localized complement activation. In this novel approach, macrophages recruited into the ischemic myocardium by complement cleavage chemotactic peptides, and binding anti-Gal-coated α-gal nanoparticles, polarize to become pro-regenerative macrophages that produce pro-regenerative cytokines and recruit stem cells. This process results in near-complete regeneration of the injured myocardium within 14 days. Future evaluation of this novel approach in larger animal models will help in determining whether trans-endocardial delivery by catheter of α-gal nanoparticles into ischemic myocardium warrants clinical application in acute MI.

## Linked entities

- **Diseases:** myocardial infarction (MONDO:0005068), heart failure (MONDO:0005252)
- **Species:** Danio rerio (taxon 7955), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Gpr34 (G protein-coupled receptor 34) [NCBI Gene 23890] {aka Lypsr1}, C5AR1 (complement C5a receptor 1) [NCBI Gene 728] {aka C5A, C5AR, C5R1, CD88}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Ms4a1 (membrane-spanning 4-domains, subfamily A, member 1) [NCBI Gene 12482] {aka Cd20, Ly-44, Ms4a2}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, C5ar1 (complement component 5a receptor 1) [NCBI Gene 12273] {aka C5aR, C5r1, Cd88, D7Msu1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, GAL (galanin and GMAP prepropeptide) [NCBI Gene 51083] {aka ETL8, GAL-GMAP, GALN, GLNN, GMAP}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, Gal (galanin and GMAP prepropeptide) [NCBI Gene 14419] {aka Galn}, Itgb1 (integrin beta 1 (fibronectin receptor beta)) [NCBI Gene 16412] {aka 4633401G24Rik, CD29, Fnrb, Gm9863, gpIIa}, Cr2 (complement receptor 2) [NCBI Gene 12902] {aka C3DR, CD21, CD35, Cr-1, Cr-2, Cr1}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Ggta1 (glycoprotein galactosyltransferase alpha 1, 3) [NCBI Gene 14594] {aka GALT, Gal, Ggta, Ggta-1, alpha Gal, alpha3GalT}, C3ar1 (complement component 3a receptor 1) [NCBI Gene 12267] {aka AZ3B, C3AR, HNFAG09}, GGTA1 (glycoprotein alpha-galactosyltransferase 1 (inactive)) [NCBI Gene 2681] {aka GGTA, GGTA1P, GLYT2, a1/3GTP}, Fabp6 (fatty acid binding protein 6) [NCBI Gene 16204] {aka GT, I-15P, I-BABP, ILBP, ILBP3, Illbp}, Cd14 (CD14 antigen) [NCBI Gene 12475], Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Timd4 (T cell immunoglobulin and mucin domain containing 4) [NCBI Gene 276891] {aka B430010N18Rik, TIM-4, Tim4}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}
- **Diseases:** Fibrosis (MESH:D005355), Wounds (MESH:D014947), Heart injuries (MESH:D006335), inflammation (MESH:D007249), skin burn injuries (MESH:D000069836), premature death (MESH:D003643), ischemic (MESH:D002545), ischemic myocardium (MESH:D017682), cancer (MESH:D009369), MI (MESH:D009203), coronary artery occlusion (MESH:D054059), heart failure (MESH:D006333), infarction (MESH:D007238), cardiac allograft vasculopathy (MESH:D006331), granuloma (MESH:D006099), ventricular wall rupture (MESH:D006341), necrotic (MESH:D009336), ischemia (MESH:D007511), skin burns (MESH:D002056)
- **Chemicals:** methanol (MESH:D000432), saline (MESH:D012965), H&amp;E (MESH:D006371), Mason (-), oxygen (MESH:D010100), PVA (MESH:D011142), carbohydrate (MESH:D002241), phospholipid (MESH:D010743), chloroform (MESH:D002725), progesterone (MESH:D011374), alcohol (MESH:D000438), glycolipids (MESH:D006017), PMX205 (MESH:C504156), calcium (MESH:D002118), clodronate (MESH:D004002), cholesterol (MESH:D002784)
- **Species:** Ambystoma mexicanum (axolotl, species) [taxon 8296], Danio rerio (leopard danio, species) [taxon 7955], Cercopithecidae (monkey, family) [taxon 9527], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Sus scrofa (pig, species) [taxon 9823]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940265/full.md

---
Source: https://tomesphere.com/paper/PMC12940265